Remove Banking Remove Clinical Trials Remove Decriminalization Remove Treatment
article thumbnail

Dentons: Cannabis Group Weekly Alert – August 2019 #3

Cannabis Law Report

US Senator Mike Crapo (R-ID) , chairman of the Senate Committee on Banking, Housing and Urban Affairs, expressed interest in addressing banking issues facing cannabis businesses operating legally in their states. The SAFE Banking Act (H.R. The SAFE Banking Act (H.R.

Banking 45
article thumbnail

Dentons’ Cannabis Group Latest Weekly Update – June 2019 #4

Cannabis Law Report

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. The panel also took up a bill sponsored by Rep. Medical / Health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/rosalind-watts-89527660/.

article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Several bills have been introduced in Congress in 2019 that call for legalizing or decriminalizing the substance.

Law 40
article thumbnail

Is Europe falling behind?

The Cannigma

Now, that’s going to matter significantly when as we advance clinical trials, as we advance product formulation as not just product formulation within pharma but all product formulation and that comes down to the initial process in relation to the supply chain of pretty hardcore standardization.

article thumbnail

Can medical cannabis survive adult-use legalization?

The Cannigma

There are no payment systems, there’s no banking and cannabis. And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. So, for example, payment systems.